The best peptide APIs manufacturer
GMP peptide, peptide product, peptide, peptide research,polypeptide APIs,china peptide company,peptid list

Abstract:

Diabetes is one of the most important chronic diseases threatening human health. According to the latest statistics of the International Diabetes Association, up to 2013, the number of diabetics in adults aged 20-79 has reached 382 million, and the prevalence rate has reached 8.3%. Among these people who have diabetes, 175 million have not been diagnosed. It is estimated that there will be 592 million people suffering from diabetes in the world by 2035.

[peptide class] lowering blood glucose of peptide's physiological function series

Diabetes is a group of metabolic diseases characterized by hyperglycemia. Hyperglycemia is caused by the deficiency of insulin secretion or the damage of its biological function, or both. The typical symptoms of diabetic patients are more than three, more drinking, more eating, more urine and weight loss. Diabetes will also have a chain reaction, which will lead to the disorder of metabolism of fat, protein, water and inorganic salt in patients with diabetes. At the same time, the disorder of metabolism of protein may occur in patients with diabetes, which makes it difficult to synthesize protein in the body, resulting in the lack of protein, the decline of body strength and the susceptibility to various infections.

In fact, insulin is an endogenous bioactive peptide. There are also many exogenous active peptides with obvious hypoglycemic function. Balsam pear, for example, has good hypoglycemic properties, especially for the treatment of type II diabetes. The main Hypoglycemic Active Components of Momordica charantia are peptides and alkaloids, such as peptide-p, peptide-k and momordoside. Scientific research has proved that the occurrence of diseases is caused by cytopathy.

Diabetes plagues hundreds of millions of hyperglycemia patients in China. Its pathology is mainly the degradation of islet cell function, inability to secrete insulin, which makes the patients' blood sugar rise, leading to various complications. Small molecule active peptide can be directly combined with islet cells, on the one hand, it can enhance the vitality of islet cells, on the other hand, it can self build new islet cells, promote the secretion of insulin, regulate the metabolism of sugar, fat and protein, solve the problem of high blood sugar in diabetic patients from the root, and realize the control and rehabilitation of diabetes.

At the same time, for the chain reaction caused by diabetes, peptides are suitable for people with low immunity, rich in arginine and glutamic acid, which can increase the volume and health of thymus, an important immune organ of the human body, and enhance immunity; when a large number of viruses invade the human body, glutamic acid can produce immune cells and repel the virus.

Shengnuo bio PRODUCT

Atosiban Acetate Injection Carbetocin Injection OctreotideAcetate Injection Enfuvirtide for injection
Thymus for injection is new Thymopentin for Injection Levosimendan Injection Atosiban Acetate Injection

INQUIRE

NAME:

EMAIL:

MASSAGE:


Best sales manager contact

Contacts Roleagh
Tel 86-28-88203630
Fax 86-28-88203630
Email roleagh@gmail.com
QQ 2539328606
Facebook LEI LI

About Shengnuo

Chengdu Shengnuo Biotechnology Co., Ltd. has "Chengdu polypeptide drug engineering technology research center" in Chengdu, mainly engaged in polypeptide, polypeptide drug and beauty peptide research. Our zero defect has passed the FDA certification, and now it has become the first-class professional peptide drug and product development, technology transfer, technical service and peptide drug industry in the scale production and export of China's parks.

Load more